Literature DB >> 9468324

Regulated expression of mature human insulin in the liver of transgenic mice.

D Mitanchez1, R Chen, J F Massias, A Porteu, A Mignon, X Bertagna, A Kahn.   

Abstract

Transgenic mice expressing either human proinsulin cDNA or mutated proinsulin cDNA in the liver were created. The human proinsulin cDNA was mutated to generate a protein cleavable by the ubiquitous prohormone convertase furin, thus leading to mature insulin peptide. All transgenic lines expressed human C-peptide in the blood, whose level varied according to nutritional conditions. High performance liquid chromatography fractionation of mouse serum revealed that mutant proinsulin was effectively processed into mature insulin in vivo. This transgenic mouse model provides a useful tool for further prospects of gene therapy of insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468324     DOI: 10.1016/s0014-5793(97)01574-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Current advances and future prospects in production of recombinant insulin and other proteins to treat diabetes mellitus.

Authors:  Sapna Bhoria; Jyoti Yadav; Honey Yadav; Darshna Chaudhary; Ranjana Jaiwal; Pawan K Jaiwal
Journal:  Biotechnol Lett       Date:  2022-04-17       Impact factor: 2.461

2.  Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene.

Authors:  Jian Xu; Yuhua Lu; Fei Ding; Xi Zhan; Mingyan Zhu; Zhiwei Wang
Journal:  World J Surg       Date:  2007-09       Impact factor: 3.352

3.  Insulin expressing hepatocytes not destroyed in transgenic NOD mice.

Authors:  Muhammad T Tabiin; Christopher P White; Grant Morahan; Bernard E Tuch
Journal:  J Autoimmune Dis       Date:  2004-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.